BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20236338)

  • 1. A prospective comparison between ICHD-II and probability menstrual migraine diagnostic criteria.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):539-50. PubMed ID: 20236338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs.
    Goldberg J; Wolf A; Silberstein S; Gebeline-Myers C; Hopkins M; Einhorn K; Tolosa JE
    Headache; 2007 Mar; 47(3):384-96. PubMed ID: 17371355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial.
    MacGregor EA; Victor TW; Hu X; Xiang Q; Puenpatom RA; Chen W; Campbell JC
    Headache; 2010 Apr; 50(4):528-38. PubMed ID: 20236340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool.
    Tepper SJ; Zatochill M; Szeto M; Sheftell F; Tepper DE; Bigal M
    Headache; 2008; 48(10):1419-25. PubMed ID: 19076645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
    Mannix LK; Loder E; Nett R; Mueller L; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
    Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical interview versus prospective headache diaries in the diagnosis of menstrual migraine without aura.
    Vetvik KG; MacGregor EA; Lundqvist C; Russell MB
    Cephalalgia; 2015 Apr; 35(5):410-6. PubMed ID: 25143553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sinus, Allergy and Migraine Study (SAMS).
    Eross E; Dodick D; Eross M
    Headache; 2007 Feb; 47(2):213-24. PubMed ID: 17300361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 375 childhood primary headache: clinical features, the agreement between clinical diagnosis and diagnoses using the international classification of headache disorders in Thai children.
    Ruangsuwan S; Sriudomkajorn S
    J Med Assoc Thai; 2007 Jul; 90(7):1309-16. PubMed ID: 17710970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria.
    Bigal ME; Rapoport AM; Tepper SJ; Sheftell FD; Lipton RB
    Headache; 2005 May; 45(5):582-9. PubMed ID: 15953277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual tension-type headache: evidence for its existence.
    Arjona A; Rubi-Callejon J; Guardado-Santervas P; Serrano-Castro P; Olivares J
    Headache; 2007 Jan; 47(1):100-3. PubMed ID: 17355502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey.
    Donnet A; Lantéri-Minet M; Aucoin F; Allaf B
    Headache; 2009 Jul; 49(7):1014-21. PubMed ID: 19486362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and biology of menstrual migraine.
    Martin VT; Lipton RB
    Headache; 2008; 48 Suppl 3():S124-30. PubMed ID: 19076658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine.
    Vetvik KG; MacGregor EA; Lundqvist C; Russell MB
    J Headache Pain; 2018 Oct; 19(1):97. PubMed ID: 30332985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of migraine related to menses: results from the AMPP study.
    Pavlović JM; Stewart WF; Bruce CA; Gorman JA; Sun H; Buse DC; Lipton RB
    J Headache Pain; 2015 Mar; 16():24. PubMed ID: 25902814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of premenstrual syndrome and their association with migraine headache.
    Martin VT; Wernke S; Mandell K; Ramadan N; Kao L; Bean J; Liu J; Zoma W; Rebar R
    Headache; 2006 Jan; 46(1):125-37. PubMed ID: 16412160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the ICHD-II criteria to the diagnosis of primary chronic headaches via a computerized structured record.
    Sarchielli P; Pedini M; Coppola F; Rossi C; Baldi A; Corbelli I; Mancini ML; Calabresi P
    Headache; 2007 Jan; 47(1):38-44. PubMed ID: 17355492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.